The results indicate that SENP1 downregulation blocks epithelial-mesenchymal transition (EMT) process and thus inhibits breast cancer cell invasion and metastasis, which is mediated via ZEB1 expression. The gene discussed is ZEB1; the disease is breast carcinoma.